Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    86,822.91
    -410.29 (-0.47%)
     

  • CMC Crypto 200

    1,333.29
    -63.24 (-4.53%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

MustGrow Biologics agrees to commercial licence agreement with Bayer covering Europe, Middle East and Africa

News Direct
·1 min read

Vancouver --News Direct-- MustGrow Biologics Corp.

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has signed a collaboration agreement with Bayer AG that focuses on the soil applications of MustGrow's mustard-based biocontrol technologies across Europe, the Middle East, and Africa (EMEA).

It's important to note that this collaboration excludes home and garden, turf, and ornamental applications.

Under this collaboration agreement, MustGrow Biologics is set to receive an initial upfront payment. Moreover, the company stands to gain additional payments tied to the achievement of specific business milestones.

ADVERTISEMENT

As a significant milestone, once commercial sales commence, MustGrow will also be entitled to receive fees from royalties and manufacturing sales.

The financial implications of this collaboration are substantial, with MustGrow anticipating that the combined value of upfront payments, milestone achievements, and Development Work could amount to an impressive sum ranging from US$35 to $40 million over several years. This projection does not even include the potential additional revenue from royalties and manufacturing sales.

This partnership between MustGrow Biologics and Bayer reflects the growing recognition of MustGrow's innovative and environmentally friendly biocontrol technologies, which have the potential to revolutionize agriculture and contribute to sustainable farming practices across the EMEA region.

The collaboration marks a significant step forward for both companies, positioning them as key players in the global agriculture industry's ongoing quest for effective, sustainable, and eco-friendly solutions.

Contact Details

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/mustgrow-biologics-agrees-to-commercial-licence-agreement-with-bayer-covering-europe-middle-east-and-africa-788026745